*HistoSonics** is a commercial-stage **medtech** company advancing the Edison® System, a novel non-invasive **sonic beam therapy based on histotripsy**. Since receiving FDA De Novo **grant** for the non-invasive destruction of liver tumors in 2023, the company has progressed beyond initial market en